Focal adhesion kinase as an immunotherapeutic target
Authors:
- 22 October 2008
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 58 (6) , 931-940
Abstract
Background Focal adhesion kinase (FAK) is a ubiquitously expressed non-receptor tyrosine kinase involved in cancer progression and metastasis that is found overexpressed in a large number of tumors such as breast, colon, prostate, melanoma, head and neck, lung and ovary. Thus, FAK could be an attractive tumor associated antigen (TAA) for developing immunotherapy against a broad type of malignancies. In this study, we determined whether predicted T cell epitopes from FAK would be able to induce anti-tumor immune cellular responses. Methods To validate FAK as a TAA recognized by CD4 helper T lymphocytes (HTL), we have combined the use of predictive peptide/MHC class II binding algorithms with in vitro vaccination of CD4 T lymphocytes from healthy individuals and melanoma patients. Results Two synthetic peptides, FAK143–157 and FAK1,000–1,014, induced HTL responses that directly recognized FAK-expressing tumor cells and autologous dendritic cells pulsed with FAK-expressing tumor cell lysates in an HLA class II-restricted manner. Moreover, since the FAK peptides were recognized by melanoma patient’s CD4 T cells, this is indicative that T cell precursors reactive with FAK already exist in peripheral blood of these patients. Conclusions Our results provide evidence that FAK functions as a TAA and describe peptide epitopes that may be used for designing T cell-based immunotherapy for FAK-expressing cancers, which could be used in combination with newly developed FAK inhibitors.Keywords
This publication has 35 references indexed in Scilit:
- Peptide epitope identification for tumor-reactive CD4 T cellsCurrent Opinion in Immunology, 2008
- Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy NumberClinical Cancer Research, 2006
- The role of focal-adhesion kinase in cancer — a new therapeutic opportunityNature Reviews Cancer, 2005
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cellsOncogene, 2004
- Differential regulation of cell motility and invasion by FAKJournal of Cell Biology, 2003
- Expression of focal adhesion kinase in normal and pathologic human prostate tissuesThe Prostate, 2002
- The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer CellsJournal of Biological Chemistry, 2000
- Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptidesImmunity, 1994
- Focal adhesion kinase: an integrin-linked protein tyrosine kinaseTrends in Cell Biology, 1993